ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ACAD Acadia Pharmaceuticals Inc

16.19
0.87 (5.68%)
プレマーケット
最終更新日: 20:06:37
15分遅延
名称 銘柄コード 市場 種別
Acadia Pharmaceuticals Inc ACAD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.87 5.68% 16.19 20:06:37
始値 安値 高値 終値 前日終値
15.32
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0107:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0105:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/3006:23EDGAR2Form 8-K - Current report
2024/5/3005:55EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:54EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:53EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/5/3005:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/5/1805:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
2024/5/1522:05BWAcadia Pharmaceuticals Announces Launch of Magnolia's Guide..
2024/5/1005:58BWAcadia Pharmaceuticals to Participate at Upcoming Investor..
2024/5/0905:10EDGAR2Form 8-K - Current report
2024/5/0905:05BWAcadia Pharmaceuticals Reports First Quarter 2024 Financial..
2024/4/3005:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
2024/4/2505:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
2024/4/2222:04BWAcadia Pharmaceuticals annonce que la présentation de drogue..
2024/4/2005:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
2024/4/1805:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
2024/4/0305:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
2024/4/0205:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
2024/3/1605:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
2024/3/1405:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
2024/3/1220:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
2024/3/1205:05EDGAR2Form 8-K - Current report
2024/3/1205:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
2024/2/2923:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
2024/2/2808:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2808:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2808:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2808:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:16EDGAR2Form 8-K - Current report
2024/2/2806:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/2/2206:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
2024/2/1421:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1406:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
2024/2/0907:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0907:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/3111:55EDGAR2Form 8-K - Current report
2024/1/3110:48BWAcadia Announces Additions to Executive Team
2024/1/2707:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2006:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..